Veeva Systems (NYSE:VEEV) Price Target Cut to $300.00 by Analysts at TD Cowen

Veeva Systems (NYSE:VEEV) had its target price dropped by equities research analysts at TD Cowen from $380.00 to $300.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the technology company’s stock. TD Cowen’s target price points to a potential upside of 54.96% from the stock’s current price.

Other research analysts have also issued reports about the stock. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. BTIG Research reaffirmed a “buy” rating and issued a $340.00 price objective on shares of Veeva Systems in a research note on Friday, November 21st. Piper Sandler decreased their target price on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating on the stock in a research report on Thursday. Jefferies Financial Group reissued a “buy” rating and issued a $330.00 target price on shares of Veeva Systems in a report on Monday, November 24th. Finally, Citigroup cut their price target on Veeva Systems from $349.00 to $319.00 and set a “buy” rating for the company in a research note on Monday, November 24th. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $284.92.

Veeva Systems Stock Up 2.7%

Shares of Veeva Systems stock traded up $5.12 during trading on Thursday, reaching $193.60. The company’s stock had a trading volume of 3,003,757 shares, compared to its average volume of 2,239,698. The business has a 50 day moving average price of $204.58 and a 200-day moving average price of $248.39. Veeva Systems has a 12-month low of $168.13 and a 12-month high of $310.50. The company has a market capitalization of $31.82 billion, a P/E ratio of 37.67, a price-to-earnings-growth ratio of 1.28 and a beta of 1.09.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The firm had revenue of $835.95 million during the quarter, compared to analysts’ expectations of $810.95 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.Veeva Systems’s revenue was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. Research analysts predict that Veeva Systems will post 4.35 EPS for the current fiscal year.

Veeva Systems announced that its board has initiated a stock buyback program on Monday, January 5th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the technology company to purchase up to 5.5% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

Insider Buying and Selling at Veeva Systems

In related news, insider Thomas D. Schwenger sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the transaction, the insider owned 23,204 shares of the company’s stock, valued at approximately $5,370,101.72. This represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 10.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Linden Thomas Advisory Services LLC grew its position in shares of Veeva Systems by 0.3% in the third quarter. Linden Thomas Advisory Services LLC now owns 12,444 shares of the technology company’s stock valued at $3,707,000 after purchasing an additional 35 shares during the period. Sigma Planning Corp grew its holdings in Veeva Systems by 1.2% in the 2nd quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock valued at $958,000 after buying an additional 39 shares during the period. Personal CFO Solutions LLC grew its holdings in Veeva Systems by 3.5% in the 3rd quarter. Personal CFO Solutions LLC now owns 1,163 shares of the technology company’s stock valued at $346,000 after buying an additional 39 shares during the period. AFT Forsyth & Company Inc. increased its stake in shares of Veeva Systems by 4.2% during the 3rd quarter. AFT Forsyth & Company Inc. now owns 984 shares of the technology company’s stock valued at $293,000 after acquiring an additional 40 shares during the last quarter. Finally, Williams Jones Wealth Management LLC. lifted its holdings in shares of Veeva Systems by 0.4% during the 3rd quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock worth $2,806,000 after acquiring an additional 40 shares during the period. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Company beat revenue and EPS estimates for Q4 and issued FY27 and Q1 guidance above consensus — management reported 16% revenue growth and raised forward EPS and revenue ranges, which supports continued top-line momentum and de‑risked near‑term expectations. Veeva Announces Fourth Quarter and Fiscal Year 2026 Results
• Positive Sentiment: Analysts cite Veeva’s AI initiatives and proprietary life‑sciences data as a durable competitive advantage that should help the company weather broader AI disruption concerns — this narrative is supporting investor confidence. Veeva Systems Analyst Says AI Push Keeps Stock Attractive
• Positive Sentiment: Veeva is signaling CRM will become a meaningful growth driver (targeting ~10% of revenue by 2030) as AI demand builds — a successful CRM expansion would diversify revenue and raise long‑term growth visibility. Veeva signals CRM to comprise 10% of revenue by 2030 as AI momentum builds
• Positive Sentiment: Several firms raised or reaffirmed positive ratings after the results (Stifel raised its PT to $245; UBS raised to $220; Morgan Stanley nudged its PT higher), providing analyst support for the rally. Analyst Price Target Actions
• Neutral Sentiment: Truist reaffirmed a “buy” rating but trimmed its price target — indicates confidence in the business but slightly more conservative near‑term expectations. Truist Reaffirms Buy
• Negative Sentiment: Several sell‑side shops trimmed price targets (Piper Sandler, Needham, RBC, Wells Fargo made cuts) and a subset lowered forecasts after the quarter — these revisions reflect concerns about growth deceleration, margin pressure, and tougher CRM competition and can cap upside until guidance execution is proven. These Analysts Cut Their Forecasts On Veeva Systems Following Q4 Results
• Negative Sentiment: Prior commentary flagged competitive pressures in CRM and the pace of AI adoption as risks — investors may remain cautious until Veeva demonstrates clear monetization of agentic/AI features and CRM share gains. Veeva Systems under pressure as earnings loom amid CRM competition

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.